Skip to main content
. 2013 Sep 18;2(5):674–686. doi: 10.1002/cam4.133

Figure 2.

Figure 2

Response rates for single-agent chemotherapies (A), combination chemotherapies (B), and chemoimmunotherapies and immunotherapy with ipilimumab (C).